NewsRx

Search our medical news database

Business & Finance

ArthroCare expects fourth quarter 2006 revenues of approximately $69.7 million

Published in Medical Patent Law Weekly, February 7th, 2007

ArthroCare Corp. (ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that it received certain patent licenses from MarcTec, settling a patent infringement lawsuit, and that ArthroCare's effective fourth quarter tax rate would be reduced.

The company also confirmed that it expects fourth quarter earnings of approximately $0.33 per share and full year earnings of approximately $1.17 per share, prior to the cumulative impact of the settlement costs and tax benefit. Fourth quarter revenues are expected to be approximately $69.7 million, at the current First Call consensus. "Revenues increased in all divisions on both a sequential...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook